Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis

被引:59
作者
Balzarini, J
Van Laethem, K
Hatse, S
Froeyen, M
Van Damme, E
Bolmstedt, A
Peumans, W
De Clercq, E
Schols, D
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Univ Hosp Leuven, Louvain, Belgium
[3] Gothenburg Univ, Dept Clin Virol, S-41124 Gothenburg, Sweden
[4] Univ Ghent, Dept Mol Biotechnol, B-9000 Ghent, Belgium
关键词
D O I
10.1124/mol.104.005082
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The plant lectins from Hippeastrum hybrid (HHA) and Galanthus nivalis (GNA) are 50,000-D tetramers showing specificity for alpha-( 1,3) and/or alpha-(1,6)-mannose oligomers. They inhibit HIV-1 infection at a 50% effective concentration of 0.2 to 0.3 mu g/ ml. Escalating HHA or GNA concentrations ( up to 500 mu g/ ml) led to the isolation of three HIV-1(III B) strains in CEM T cell cultures that were highly resistant to HHA and GNA, several other related mannose-specific plant lectins, and the monoclonal antibody 2G12, modestly resistant to the mannose-specific cyanovirin, which is derived from a blue-green alga, but fully susceptible to other HIV entry inhibitors as well as HIV reverse transcriptase inhibitors. These mutant virus strains were devoid of up to seven or eight of 22 glycosylation sites in the viral envelope glycoprotein gp120 because of mutations at the Asn or Thr/Ser sites of the N-glycosylation motifs. In one of the strains, a novel glycosylation site was created near a deleted glycosylation site. The affected glycosylation sites were predominantly clustered in regions of gp120 that are not involved in the direct interaction with either CD4, CCR5, CXCR4, or gp41. The mutant viruses containing the deleted glycosylation sites were markedly more infectious in CEM T-cell cultures than wild-type virus.
引用
收藏
页码:1556 / 1565
页数:10
相关论文
共 41 条
  • [1] INHIBITORY EFFECTS OF NOVEL MANNOSE-BINDING LECTINS ON HIV-INFECTIVITY AND SYNCYTIUM FORMATION
    ANIMASHAUN, T
    MAHMOOD, N
    HAY, AJ
    HUGHES, RC
    [J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (03) : 145 - 153
  • [2] Balzarini J, 2004, ANTIVIR RES, V62, pA76
  • [3] Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins
    Balzarini, J
    Van Laethem, K
    Hatse, S
    Vermeire, K
    De Clercq, ER
    Peumans, W
    Van Damme, E
    Vandamme, AM
    Böhlmstedt, A
    Schols, D
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (19) : 10617 - 10627
  • [4] ALPHA-(1-3)-D-MANNOSE-SPECIFIC AND ALPHA-(1-6)-D-MANNOSE-SPECIFIC PLANT-LECTINS ARE MARKEDLY INHIBITORY TO HUMAN-IMMUNODEFICIENCY-VIRUS AND CYTOMEGALOVIRUS INFECTIONS INVITRO
    BALZARINI, J
    SCHOLS, D
    NEYTS, J
    VANDAMME, E
    PEUMANS, W
    DECLERCQ, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) : 410 - 416
  • [5] THE MANNOSE-SPECIFIC PLANT-LECTINS FROM CYMBIDIUM HYBRID AND EPIPACTIS-HELLEBORINE AND THE (N-ACETYLGLUCOSAMINE)N-SPECIFIC PLANT LECTIN FROM URTICA-DIOICA ARE POTENT AND SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS AND CYTOMEGALOVIRUS REPLICATION INVITRO
    BALZARINI, J
    NEYTS, J
    SCHOLS, D
    HOSOYA, M
    VANDAMME, E
    PEUMANS, W
    DECLERCQ, E
    [J]. ANTIVIRAL RESEARCH, 1992, 18 (02) : 191 - 207
  • [6] Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection
    Balzarini, J
    Hatse, S
    Vermeire, K
    Princen, K
    Aquaro, S
    Perno, CF
    De Clercq, E
    Egberink, H
    Vanden Mooter, G
    Peumans, W
    Van Damme, E
    Schols, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) : 3858 - 3870
  • [7] Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan
    Bolmstedt, A
    Hinkula, J
    Rowcliffe, E
    Biller, M
    Wahren, B
    Olofsson, S
    [J]. VACCINE, 2001, 20 (3-4) : 397 - 405
  • [8] HIV-inhibitory natural products part 71 - Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner
    Bolmstedt, AJ
    O'Keefe, BR
    Shenoy, SR
    Mcmahon, JB
    Boyd, MR
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (05) : 949 - 954
  • [9] Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development
    Boyd, MR
    Gustafson, KR
    McMahon, JB
    Shoemaker, RH
    OKeefe, BR
    Mori, T
    Gulakowski, RJ
    Wu, L
    Rivera, MI
    Laurencot, CM
    Currens, MJ
    Cardellina, JH
    Buckheit, RW
    Nara, PL
    Pannell, LK
    Sowder, RC
    Henderson, LE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1521 - 1530
  • [10] A GENERAL-MODEL FOR THE SURFACE GLYCOPROTEINS OF HIV AND OTHER RETROVIRUSES
    GALLAHER, WR
    BALL, JM
    GARRY, RF
    MARTINAMEDEE, AM
    MONTELARO, RC
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (02) : 191 - 202